- The study was posted online Tuesday but had not been peer-reviewed yet. The study, conducted by a group of scientists from Icahn School of Medicine at Mount Sinai, used results from 1,343 people in the New York City area.
- The study relied on a test developed by Florian Krammer, a virologist at the Icahn School of Medicine at Mount Sinai, that has a less than 1 percent chance of producing false-positive results.
- The study found no difference in antibody production by degree of sickness, age, or sex.
- The study hints that anyone who recovers from the infection may safely return to work. However, it is still unclear how long the antibody protection might last.